Yao-An Shen

13PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 13, 2026
Fibronectin 1 mediates pressure-induced aggressive phenotypes in colorectal cancer cells and cancer stem cells.

|Jun 01, 2026
Sclerofish A and B: Two Pairs of Enantiomeric Diterpenoids Featuring a 4/7/6-Fused Tricyclic Scaffold from the Soft Coral Sclerophytum humesi.

|Apr 14, 2026
Targeting glutamine metabolism combined with a nanoradioenhancer in radioresistant hepatocellular carcinoma.

Chia-Chun Kuo, Yao-Chen Chuang, Ping-Hsiu Wu

|Jul 14, 2025
Inhibition of Glutamine Metabolism Attenuates Tumor Progression Through Remodeling of the Macrophage Immune Microenvironment.

Tianhe Li, Sepehr Akhtarkhavari, Sumeng Qi

|Jan 27, 2025
Inhibition of Glutamine Metabolism Suppresses Tumor Progression through Remodeling of the Macrophage Immune Microenvironment.

Tianhe Li, Sepehr Akhtarkhavari, Tu-Yung Chang

|Jun 27, 2024
Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor.

Lin-Yu Chen, Yao-An Shen, Ling-Hui Chu

Pageof 3

Frequent Collaborators

3 joint publications

Yao-Chen Chuang

2 joint publications

Ie-Ming Shih

2 joint publications

Stephanie Gaillard

2 joint publications

Barbara Slusher